Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Manodoro, S.; Frigerio, M.; Cola, A.; Spelzini, F.; Milani, R. Risk factors for recurrence after hysterectomy plus native-tissue repair as primary treatment for genital prolapse. Int. Urogynecol. J. 2018, 29, 145–151. [Google Scholar] [CrossRef] [PubMed]
- Frigerio, M.; Mastrolia, S.A.; Spelzini, F.; Manodoro, S.; Yohay, D.; Weintraub, A.Y. Long-term effects of episiotomy on urinary incontinence and pelvic organ prolapse: A systematic review. Arch. Gynecol. Obstet. 2019, 299, 317–325. [Google Scholar] [CrossRef] [PubMed]
- Milani, R.; Frigerio, M.; Vellucci, F.L.; Palmieri, S.; Spelzini, F.; Manodoro, S. Transvaginal native-tissue repair of vaginal vault prolapse. Minerva Ginecol. 2018, 70, 371–377. [Google Scholar] [CrossRef] [PubMed]
- Milani, R.; Frigerio, M.; Spelzini, F.; Manodoro, S. Transvaginal uterosacral ligament suspension for posthysterectomy vaginal vault prolapse repair. Int. Urogynecol. J. 2017, 28, 1421–1423. [Google Scholar] [CrossRef] [PubMed]
- Frigerio, M.; Regini, C.; Manodoro, S.; Spelzini, F.; Milani, R. Minisling efficacy in obese versus non-obese patients for treatment of stress urinary incontinence. Minerva Ginecol. 2017, 69, 533–537. [Google Scholar] [CrossRef] [PubMed]
- Manodoro, S.; Spelzini, F.; Cesana, M.C.; Frigerio, M.; Maggioni, D.; Ceresa, C.; Penati, C.; Sicuri, M.; Fruscio, R.; Nicolini, G.; et al. Histologic and metabolic assessment in a cohort of patients with genital prolapse: Preoperative stage and recurrence investigations. Minerva Ginecol. 2017, 69, 233–238. [Google Scholar] [CrossRef] [PubMed]
- Frigerio, M.; Manodoro, S.; Palmieri, S.; Spelzini, F.; Milani, R. Risk factors for stress urinary incontinence after native-tissue vaginal repair of pelvic organ prolapse. Int. J. Gynaecol. Obstet. 2018, 141, 349–353. [Google Scholar] [CrossRef] [PubMed]
- Palmieri, S.; Frigerio, M.; Spelzini, F.; Manodoro, S.; Milani, R. Risk factors for stress urinary incontinence recurrence after single incision sling. Neurourol. Urodyn. 2018, 37, 1711–1716. [Google Scholar] [CrossRef]
- Johnston, S.L. Pelvic floor dysfunction in midlife women. Climacteric 2019, 22, 270–276. [Google Scholar] [CrossRef]
- Portman, D.J.; Gass, M.L. Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause 2014, 21, 1063–1068. [Google Scholar] [CrossRef]
- Ruffolo, A.F.; Braga, A.; Torella, M.; Frigerio, M.; Cimmino, C.; De Rosa, A.; Sorice, P.; Castronovo, F.; Salvatore, S.; Serati, M. Vaginal Laser Therapy for Female Stress Urinary Incontinence: New Solutions for a Well-Known Issue-A Concise Review. Medicina 2022, 58, 512. [Google Scholar] [CrossRef]
- Samuels, J.B.; Garcia, M.A. Treatment to External Labia and Vaginal Canal With CO2 Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women. Aesthet. Surg. J. 2019, 39, 83–93. [Google Scholar] [CrossRef] [PubMed]
- Gaspar, A.; Brandi, H.; Gomez, V.; Luque, D. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg. Med. 2017, 49, 160–168. [Google Scholar] [CrossRef] [PubMed]
- North American Menopause Society. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013, 20, 888–902. [Google Scholar] [CrossRef] [PubMed]
- Santoro, N.; Komi, J. Prevalence and impact of vaginal symptoms among postmenopausal women. J. Sex Med. 2009, 6, 2133–2142. [Google Scholar] [CrossRef]
- Bachmann, G.A.; Nevadunsky, N.S. Diagnosis and treatment of atrophic vaginitis. Am. Fam. Physician 2000, 61, 3090–3096. [Google Scholar] [PubMed]
- Iosif, C.S.; Bekassy, Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet. Gynecol. Scand. 1984, 63, 257–260. [Google Scholar] [CrossRef]
- Foster, R.T., Sr. Uncomplicated urinary tract infections in women. Obstet. Gynecol. Clin. N. Am. 2008, 35, 235–248. [Google Scholar] [CrossRef]
- Pérez-López, F.R.; Phillips, N.; Vieira-Baptista, P.; Cohen-Sacher, B.; Fialho, S.C.A.V.; Stockdale, C.K. Management of postmenopausal vulvovaginal atrophy: Recommendations of the International Society for the Study of Vulvovaginal Disease. Gynecol. Endocrinol. 2021, 37, 746–752. [Google Scholar] [CrossRef]
- Harris, B.S.; Bishop, K.C.; Kuller, J.A.; Ford, A.C.; Muasher, L.C.; Cantrell, S.E.; Price, T.M. Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy. Menopause 2020, 27, 243–248. [Google Scholar] [CrossRef]
- Veron, L.; Wehrer, D.; Annerose-Zéphir, G.; Suciu, V.; Delaloge, S.; Pistilli, B.; Chaltiel, D.; Pautier, P. Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: A prospective study with long-term follow-up. Breast Cancer Res. Treat. 2021, 188, 501–509. [Google Scholar] [CrossRef] [PubMed]
- Baumgart, J.; Nilsson, K.; Evers, A.S.; Kallak, T.K.; Poromaa, I.S. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause 2013, 20, 162–168. [Google Scholar] [CrossRef] [PubMed]
- Fallowfeld, L.; Cella, D.; Cuzick, J.; Francis, S.; Locker, G.; Howell, A. Quality of life of postmenopausal women in the arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial. J. Clin. Oncol. 2004, 22, 4261–4271. [Google Scholar] [CrossRef] [PubMed]
- Oberguggenberger, A.; Martini, C.; Huber, N.; Fallowfield, L.; Hubalek, M.; Daniaux, M.; Sperner-Unterweger, B.; Holzner, B.; Sztankay, M.; Gamper, E.; et al. Self-reported sexual health: Breast cancer survivors compared to women from the general population—An observational study. BMC Cancer 2017, 17, 599. [Google Scholar] [CrossRef] [PubMed]
- Hawkins, Y.; Ussher, J.; Gilbert, E.; Perz, J.; Sandoval, M.; Sundquist, K. Changes in sexuality and intimacy after the diagnosis and treatment of cancer: The experience of partners in a sexual relationship with a person with cancer. Cancer Nurs. 2009, 32, 271–280. [Google Scholar] [CrossRef] [PubMed]
- Pistilli, B.; Paci, A.; Ferreira, A.R.; Di Meglio, A.; Poinsignon, V.; Bardet, A.; Menvielle, G.; Dumas, A.; Pinto, S.; Dauchy, S.; et al. Serum detection of nonadherence to adjuvant tamoxifen and breast cancer recurrence risk. J. Clin. Oncol. J. Am. Soc. Clin. Oncol. 2020, 38, 2762. [Google Scholar] [CrossRef] [PubMed]
- Santen, R.J.; Stuenkel, C.A.; Davis, S.R.; Pinkerton, J.V.; Gompel, A.; Lumsden, M.A. Managing menopausal symptoms and associated clinical issues in breast cancer survivors. J. Clin. Endocrinol. Metab. 2017, 102, 3647–3661. [Google Scholar] [CrossRef] [PubMed]
- Temkinm, S.M.l.; Mallen, A.; Bellavance, E.; Rubinsak, L.; Wenhamm, R.M. The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions. Cancer 2019, 125, 499–514. [Google Scholar] [CrossRef]
- Kapoor, E.; Benrubi, D.; Faubion, S.S. Menopausal hormone therapy in gynecologic cancer survivors: A review of the evidence and practice recommendations. Clin. Obstet. Gynecol. 2018, 61, 488–495. [Google Scholar] [CrossRef]
- Johnston, S.L.; Farrell, S.A.; Bouchard, C.; Farrell, S.A.; Beckerson, L.A.; Comeau, M.; Johnston, S.L.; Lefebvre, G.; Papaioannou, A. SOGC Joint Committee-Clinical Practice Gynaecology and Urogynaecology. The detection and management of vaginal atrophy. J. Obstet. Gynaecol. Can. 2004, 26, 503–515. [Google Scholar]
- Fitzpatrick, R.E.; Geronemus, R.G.; Goldberg, D.J.; Kaminer, M.; Kilmer, S.; Ruiz-Esparza, J. Multi-center study of noninvasive radiofrequency for periorbital tissue tightening. Lasers Surg. Med. 2003, 33, 232–342. [Google Scholar] [CrossRef] [PubMed]
- Fitzpatrick, R.E. Maximizing benefits and minimizing risk with CO2 laser resurfacing. Dermatol. Clin. 2002, 20, 77–86. [Google Scholar] [CrossRef] [PubMed]
- Lee, M.W. Combination 532-nm and 1064-nm lasers for noninvasive skin rejuvenation and toning. Arch. Dermatol. 2003, 139, 1265–1276, Erratum in: Arch. Dermatol. 2004, 140, 625. [Google Scholar] [CrossRef]
- Alster, T.S.; Lupton, J.R. Nonablative cutaneous remodeling using radiofrequency devices. Clin. Dermatol. 2007, 25, 487–491. [Google Scholar] [CrossRef] [PubMed]
- Angioni, S.; Nappi, L.; Sorrentino, F.; Peiretti, M.; Daniilidis, A.; Pontis, A.; Tinelli, R.; D’Alterio, M.N. Laparoscopic treatment of deep endometriosis with a diode laser: Our experience. Arch. Gynecol. Obstet. 2021, 304, 1221–1231. [Google Scholar] [CrossRef] [PubMed]
- Guerette, N.L. Safety and Efficacy of Hybrid Fractional Laser (1470 nm and 2940 nm) for Symptoms of Genitourinary Syndrome of Menopause: 12 Month Prospective Multi-Center Study. J. Minim. Invasive Gynecol. 2019, 26, S70. [Google Scholar] [CrossRef]
- Weber, M.A.; Limpens, J.; Roovers, J.P.W.R. Assessment of vaginal atrophy: A review. Int. Urogynecol. J. 2015, 26, 15–28. [Google Scholar] [CrossRef] [PubMed]
- Benini, V.; Ruffolo, A.F.; Casiraghi, A.; Degli Uomini, R.S.; Frigerio, M.; Braga, A.; Serati, M.; Torella, M.; Candiani, M.; Salvatore, S. New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review. Medicina 2022, 58, 770. [Google Scholar] [CrossRef]
- Filocamo, M.T.; Serati, M.; Li Marzi, V.; Costantini, E.; Milanesi, M.; Pietropaolo, A.; Polledro, P.; Gentile, B.; Maruccia, S.; Fornia, S.; et al. The Female Sexual Function Index (FSFI): Linguistic validation of the Italian version. J. Sex Med. 2014, 11, 447–453. [Google Scholar] [CrossRef]
- Frigerio, M.; Barba, M.; Cola, A.; Marino, G.; Volontè, S.; Melocchi, T.; De Vicari, D.; Maruccia, S. Flat Magnetic Stimulation for Stress Urinary Incontinence: A Prospective Comparison Study. Bioengineering 2023, 10, 295. [Google Scholar] [CrossRef]
- Barba, M.; Cola, A.; Rezzan, G.; Costa, C.; Melocchi, T.; De Vicari, D.; Terzoni, S.; Frigerio, M.; Maruccia, S. Flat Magnetic Stimulation for Stress Urinary Incontinence: A 3-Month Follow-Up Study. Healthcare 2023, 11, 1730. [Google Scholar] [CrossRef] [PubMed]
- Kingsberg, S.A.; Krychman, M.; Graham, S.; Bernick, B.; Mirkin, S. The Women’s EMPOWER Survey: Identifying Women’s Perceptions on Vulvar and Vaginal Atrophy and Its Treatment. J. Sex. Med. 2017, 14, 413–424. [Google Scholar] [CrossRef] [PubMed]
- Biglia, N.; Bounous, V.E.; Sgro, L.G.; D’Alonzo, M.; Pecchio, S.; Nappi, R.E. Genitourinary Syndrome of Menopause in Breast. Cancer Survivors: Are We Facing New and Safe Hopes? Clin. Breast Cancer 2015, 15, 413–420. [Google Scholar] [CrossRef]
- Faubion, S.S.; Kingsberg, S.A.; Clark, A.L.; Kaunitz, A.M.; Spadt, S.K.; Larkin, L.C.; Mitchell, C.M.; Shifren, J.L.; Simon, J.A.; McClung, M.R. The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society. Menopause 2020, 27, 976–992. [Google Scholar]
- Palacios, S.; Castelo-Branco, C.; Currie, H.; Mijatovic, V.; Nappi, R.E.; Simon, J.; Rees, M. Maturitas Update on management of genitourinary syndrome of menopause: A practical guide. Maturitas 2018, 82, 308–313. [Google Scholar] [CrossRef] [PubMed]
- Garzon, S.; Apostolopoulos, V.; Stojanovska, L.; Ferrari, F.; Mathyk, B.A.; Laganà, A.S. Non-oestrogenic modalities to reverse urogenital aging. Menopausal Rev. 2021, 20, 140–147. [Google Scholar] [CrossRef] [PubMed]
- Filippini, M.; Porcari, I.; Ruffolo, A.F.; Casiraghi, A.; Farinelli, M.; Uccella, S.; Franchi, M.; Candiani, M.; Salvatore, S. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis. J. Sex. Med. 2022, 19, 452–470. [Google Scholar] [CrossRef]
- Sokol, E.R.; Karram, M.M. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy. Menopause 2016, 23, 1102–1107. [Google Scholar] [CrossRef]
- Barber, M.A.; Eguiluz, I. Patient Satisfaction with Vaginal Erbium Laser Treatment of Stress Urinary Incontinence, Vaginal Relaxation Syndrome and Genito-urinary Syndrome of Menopause. Laser Health Acad. 2016, 2016, 18–23. [Google Scholar]
- Bojanini, B.; Juan, F.; Mejía, C.; Alexandra, M. Laser treatment of vaginal atrophy in post-menopause and post-gynecological cancer patients. Laser Health Acad. 2014, 1, 65–71. [Google Scholar]
- Kovalenkol, M.V.; Manna, L.; Cabot, A.; Hens, Z.; Talapinl, D.V.; Kagan, C.R.; Klimov, V.I.; Rogach, A.L.; Reiss, P.; Milliron, D.J.; et al. Prospects of nanoscience with nanocrystals. ACS Nano 2015, 9, 1012–1057. [Google Scholar] [CrossRef] [PubMed]
- Nappi, L.; Pontis, A.; Sorrentino, F.; Greco, P.; Angioni, S. Hysteroscopic metroplasty for the septate uterus with diode laser: A pilot study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2016, 206, 32–35. [Google Scholar] [CrossRef] [PubMed]
- Nappi, L.; Sorrentino, F.; Angioni, S.; Pontis, A.; Litta, P.; Greco, P. Feasibility of hysteroscopic endometrial polypectomy using a new dual wavelengths laser system (DWLS): Preliminary results of a pilot study. Arch. Gynecol. Obstet. 2017, 295, 3–7. [Google Scholar] [CrossRef] [PubMed]
Total FSFI-19 Score | 11.0 ± 8.5 |
| 3.8 ± 1.6 |
| 6.0 ± 5.7 |
| 5.8 ± 5.8 |
| 4.2 ± 4.7 |
| 6.0 ± 4.4 |
| 3.5 ± 4.2 |
VHI score | 12.2 ± 2.8 |
Symptom VAS | 69.2 ± 25.9 |
T0 | T1 | p-Value | |
---|---|---|---|
Total FSFI-19 Score | 11.0 ± 8.5 | 15.7 ± 9.5 | 0.002 |
| 3.8 ± 1.6 | 4.7 ± 2.0 | 0.009 |
| 6.0 ± 5.7 | 8.9 ± 5.7 | 0.007 |
| 5.8 ± 5.8 | 8.4 ± 6.5 | 0.01 |
| 4.2 ± 4.7 | 6.2 ± 5.3 | 0.012 |
| 6.0 ± 4.4 | 7.4 ± 4.5 | 0.034 |
| 3.5 ± 4.2 | 5.6 ± 5.5 | 0.017 |
VHI score | 12.2 ± 2.8 | 15.4 ± 3.6 | <0.001 |
Symptom VAS | 69.2 ± 25.9 | 43.5 ± 27.6 | <0.001 |
PGI-I | n/A | 2.8 ± 0.9 | n/A |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Barba, M.; Cola, A.; De Vicari, D.; Costa, C.; Castelli, A.P.; Volontè, S.; Fruscio, R.; Frigerio, M. Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause. Bioengineering 2023, 10, 1158. https://doi.org/10.3390/bioengineering10101158
Barba M, Cola A, De Vicari D, Costa C, Castelli AP, Volontè S, Fruscio R, Frigerio M. Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause. Bioengineering. 2023; 10(10):1158. https://doi.org/10.3390/bioengineering10101158
Chicago/Turabian StyleBarba, Marta, Alice Cola, Desirèe De Vicari, Clarissa Costa, Arianna Petra Castelli, Silvia Volontè, Robert Fruscio, and Matteo Frigerio. 2023. "Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause" Bioengineering 10, no. 10: 1158. https://doi.org/10.3390/bioengineering10101158